Literature DB >> 31020888

New insights in the treatment of patients with solitary bone plasmacytoma.

Kayane Mheidly1,2, Thierry Lamy De La Chapelle1, Mathilde Hunault3, Lotfi Benboubker4, Mohamed Benchalal5, Philippe Moreau6, Alix Baugier de Materre7, Olivier Decaux1, Kamel Laribi2.   

Abstract

Entities:  

Year:  2019        PMID： 31020888     DOI： 10.1080/10428194.2019.1605067

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  5 in total

1.  Solitary plasmacytoma of maxillofacial bones: correlation of CT features with pathological findings.

Authors:  Yu Liu; Kaicheng Li
Journal:  Dentomaxillofac Radiol       Date:  2019-10-10       Impact factor: 2.419

Review 2.  Pathological axis fracture secondary to a solitary bone plasmacytoma: Two cases and a literature review.

Authors:  Ratko Yurac; Alvaro Silva; Matias Delgado; Marilaura Nuñez; Juan Lopez; Bartolome Marre
Journal:  Surg Neurol Int       Date:  2021-04-14

3.  Serum paraprotein persistence and size determine outcome in a cohort of patients with a modern definition of plasmacytoma with up to 19 years of follow up.

Authors:  Elisabet E Manasanch; Chutima Kunacheewa; Catherine M Claussen; Hans C Lee; Sheeba K Thomas; Jill Gunther; Chelsea C Pinnix; Bouthaina S Dabaja; Behrang Amini; Raymond Alexanian; Robert Z Orlowski; Wenli Dong; Lei Feng; Donna M Weber
Journal:  Blood Cancer J       Date:  2021-02-08       Impact factor: 11.037

4.  Solitary Primary Intracranial Extramedullary Plasmacytoma With Lymph Node Metastasis.

Authors:  Anna-Lena Meinhardt; Christopher W Sandifer; Manish Dave
Journal:  Cureus       Date:  2022-04-02

5.  Maximizing the Clinical Benefit of Radiotherapy in Solitary Plasmacytoma: An International Multicenter Analysis.

Authors:  Khaled Elsayad; Michael Oertel; Laila König; Sebastian Hüske; Emmanuelle Le Ray; Mohamed A M Meheissen; Amr Abdelaziz Elsaid; Essam Elfaham; Jürgen Debus; Youlia Kirova; Klaus Herfarth; Hans Theodor Eich
Journal:  Cancers (Basel)       Date:  2020-03-13       Impact factor: 6.639
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.